Ardizzoni A - Search Results

1

Mutations in K-ras codon 12 detected in plasma DNA are not an indicator of disease in patients with non-small cell lung cancer.

Trombino S, Neri M, Puntoni R, Angelini C, Loprevite M, Cesario A, Granone P, Imperatori A, Dominioni L, Ardizzoni A, Filiberti R, Russo P. Trombino S, et al. Among authors: ardizzoni a. Clin Chem. 2005 Jul;51(7):1313-4. doi: 10.1373/clinchem.2004.043976. Clin Chem. 2005. PMID: 15976131 No abstract available.

2

Pre-clinical evaluation of new antineoplastic agents in NSCLC cell lines: evidence of histological subtype-dependent cytotoxicity.

Loprevite M, Favoni RE, de Cupis A, Pirani P, Merlo F, Grossi F, Ardizzoni A. Loprevite M, et al. Among authors: ardizzoni a. Int J Oncol. 1999 Oct;15(4):787-92. doi: 10.3892/ijo.15.4.787. Int J Oncol. 1999. PMID: 10493963

3

The role of systemic chemotherapy in the treatment of brain metastases from small-cell lung cancer.

Grossi F, Scolaro T, Tixi L, Loprevite M, Ardizzoni A. Grossi F, et al. Among authors: ardizzoni a. Crit Rev Oncol Hematol. 2001 Jan;37(1):61-7. doi: 10.1016/s1040-8428(00)00098-6. Crit Rev Oncol Hematol. 2001. PMID: 11164720 Review.

4

Interaction between novel anticancer agents and radiation in non-small cell lung cancer cell lines.

Loprevite M, Favoni RE, de Cupis A, Pirani P, Pietra G, Bruno S, Grossi F, Scolaro T, Ardizzoni A. Loprevite M, et al. Among authors: ardizzoni a. Lung Cancer. 2001 Jul;33(1):27-39. doi: 10.1016/s0169-5002(00)00247-6. Lung Cancer. 2001. PMID: 11429193

5

Study of pretreatment serum levels of HER-2/neu oncoprotein as a prognostic and predictive factor in patients with advanced nonsmall cell lung carcinoma.

Ardizzoni A, Cafferata MA, Paganuzzi M, Filiberti R, Marroni P, Neri M, Fontana V, Nicoló G, Perdelli L, Stampino CG, Rosso R, Puntoni R. Ardizzoni A, et al. Cancer. 2001 Oct 1;92(7):1896-904. Cancer. 2001. PMID: 11745263

6

c-erbB-2 protein in serum of primary lung cancer patients.

Filiberti R, Marroni P, Paganuzzi M, Izzo V, Padovani P, Cafferata M, Ardizzoni A, Neri M, Raimondi L, Puntoni R. Filiberti R, et al. Among authors: ardizzoni a. Cancer Detect Prev. 2002;26(1):64-8. doi: 10.1016/s0361-090x(02)00014-4. Cancer Detect Prev. 2002. PMID: 12088205

7

Histone deacetylation inhibitors.

Ardizzoni A, Loprevite M. Ardizzoni A, et al. Suppl Tumori. 2002 Jul-Aug;1(4):S52-4. Suppl Tumori. 2002. PMID: 12415821 Review. No abstract available.

8

Prognostic significance of K-ras, p53, bcl-2, PCNA, CD34 in radically resected non-small cell lung cancers.

Grossi F, Loprevite M, Chiaramondia M, Ceppa P, Pera C, Ratto GB, Serrano J, Ferrara GB, Costa R, Boni L, Ardizzoni A. Grossi F, et al. Among authors: ardizzoni a. Eur J Cancer. 2003 Jun;39(9):1242-50. doi: 10.1016/s0959-8049(03)00232-6. Eur J Cancer. 2003. PMID: 12763212

9

In vitro study of farnesyltransferase inhibitor SCH 66336, in combination with chemotherapy and radiation, in non-small cell lung cancer cell lines.

Loprevite M, Favoni RE, De Cupis A, Scolaro T, Semino C, Mazzanti P, Ardizzoni A. Loprevite M, et al. Among authors: ardizzoni a. Oncol Rep. 2004 Feb;11(2):407-14. Oncol Rep. 2004. PMID: 14719076

10

Farnesylated proteins as anticancer drug targets: from laboratory to the clinic.

Russo P, Loprevite M, Cesario A, Ardizzoni A. Russo P, et al. Among authors: ardizzoni a. Curr Med Chem Anticancer Agents. 2004 Mar;4(2):123-38. doi: 10.2174/1568011043482098. Curr Med Chem Anticancer Agents. 2004. PMID: 15032718 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

499 results

Search Page

Filters